MyAverix Finance
WAR · Healthcare
Synthaverse S.A. (SVE)
Biotechnology
Synthaverse S.A. (SVE) is listed on WAR in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for SVE
Synthaverse S.A. (SVE) — FAQ
What is SVE's P/E ratio?
The price-to-earnings (P/E) ratio for Synthaverse S.A. (SVE) is 25.00 (data as of 2026-05-24).
Does Synthaverse S.A. pay a dividend?
Dividend yield is not available in the current snapshot for Synthaverse S.A. (SVE). Check the MyAverix Finance app for the latest dividend data.
What sector is Synthaverse S.A. in?
Synthaverse S.A. (SVE) is classified in the Healthcare sector (Biotechnology industry).
What exchange is SVE listed on?
SVE is listed on WAR.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.